These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29728374)

  • 1. Association of Diabetic Status and Glycemic Control With Ischemic and Bleeding Outcomes in Patients With Stable Coronary Artery Disease: The 5-Year CORONOR Registry.
    Lemesle G; Meurice T; Tricot O; Lamblin N; Bauters C
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
    Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
    Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Incidence and Prognostic Impact of Ischemic, Major Bleeding and Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From the CORONOR Registry.
    Lemesle G; Lamblin N; Schurtz G; Labreuche J; Duhamel A; Verdier B; Steg PG; Bauters C
    Circulation; 2024 May; 149(22):1708-1716. PubMed ID: 38660793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. J-curve relationship between long term glycemic control and mortality in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Choi IJ; Choo EH; Kim HJ; Lim S; Moon D; Lee KY; Hwang BH; Kim CJ; Park MW; Lee JM; Park CS; Kim HY; Yoo KD; Jeon DS; Chung WS; Kim MC; Jeong MH; Ahn Y; Chang K
    Cardiovasc Diabetol; 2021 Dec; 20(1):234. PubMed ID: 34911555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials.
    Ploumen EH; Pinxterhuis TH; Zocca P; Roguin A; Anthonio RL; Schotborgh CE; Benit E; Aminian A; Danse PW; Doggen CJM; von Birgelen C; Kok MM
    Cardiovasc Diabetol; 2021 Oct; 20(1):217. PubMed ID: 34717627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elective Coronary Revascularization Procedures in Patients With Stable Coronary Artery Disease: Incidence, Determinants, and Outcome (From the CORONOR Study).
    Hamon M; Lemesle G; Meurice T; Tricot O; Lamblin N; Bauters C
    JACC Cardiovasc Interv; 2018 May; 11(9):868-875. PubMed ID: 29747917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incident Myocardial Infarction and Very Late Stent Thrombosis in Outpatients With Stable Coronary Artery Disease.
    Lemesle G; Tricot O; Meurice T; Lallemant R; Delomez M; Equine O; Lamblin N; Bauters C
    J Am Coll Cardiol; 2017 May; 69(17):2149-2156. PubMed ID: 28449776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of preprocedural glycemic control on clinical outcomes of endovascular therapy in diabetic patients with lower extremity artery disease: an analysis from a Korean multicenter retrospective registry cohort.
    Cha JJ; Kim H; Ko YG; Choi D; Lee JH; Yoon CH; Chae IH; Yu CW; Lee SW; Lee SR; Choi SH; Koh YS; Min PK;
    Cardiovasc Diabetol; 2020 Jun; 19(1):97. PubMed ID: 32571352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual antiplatelet therapy in patients with stable coronary artery disease in modern practice: prevalence, correlates, and impact on prognosis (from the Suivi d'une cohorte de patients COROnariens stables en region NORd-Pas-de-Calais study).
    Lemesle G; Lamblin N; Meurice T; Tricot O; Lallemant R; Nugue O; Delomez M; Equine O; Tondeux S; Bauters C
    Am Heart J; 2014 Oct; 168(4):479-86. PubMed ID: 25262257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting.
    Kassaian SE; Goodarzynejad H; Boroumand MA; Salarifar M; Masoudkabir F; Mohajeri-Tehrani MR; Pourhoseini H; Sadeghian S; Ramezanpour N; Alidoosti M; Hakki E; Saadat S; Nematipour E
    Cardiovasc Diabetol; 2012 Jul; 11():82. PubMed ID: 22805289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity of Glycemic Control Affects Long-Term Survival After Coronary Artery Bypass Graft Surgery.
    Robich MP; Iribarne A; Leavitt BJ; Malenka DJ; Quinn RD; Olmstead EM; Ross CS; Sawyer DB; Klemperer JD; Clough RA; Kramer RS; Baribeau YR; Sardella GL; DiScipio AW;
    Ann Thorac Surg; 2019 Feb; 107(2):477-484. PubMed ID: 30273572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation.
    Chan YH; Chuang C; Chan CC; Lee HF; Huang YC; Huang YT; Chang SH; Wang CL; Chao TF; Kuo CT; Yeh YH; Chen SA
    Cardiovasc Diabetol; 2020 Mar; 19(1):30. PubMed ID: 32156277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
    Menon V; Kumar A; Patel DR; John JS; Wolski KE; McErlean E; Riesmeyer JS; Weerakkody G; Ruotolo G; Cremer PC; Nicholls SJ; Lincoff AM; Nissen SE
    J Am Heart Assoc; 2020 Jan; 9(1):e014328. PubMed ID: 31852422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.
    Lemesle G; Ducrocq G; Elbez Y; Van Belle E; Goto S; Cannon CP; Bauters C; Bhatt DL; Steg PG;
    Clin Cardiol; 2017 Oct; 40(10):932-939. PubMed ID: 28692742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease.
    Liu SL; Wu NQ; Shi HW; Dong Q; Dong QT; Gao Y; Guo YL; Li JJ
    Cardiovasc Diabetol; 2020 Mar; 19(1):36. PubMed ID: 32192491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of diabetic medications on creatine kinase-myocardial band levels in patients undergoing coronary artery bypass surgery.
    Engoren M; Zacharias A; Habib RH; Schwann TA; Riordan CJ; Durham SJ; Shah A
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):793-6. PubMed ID: 19661119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High hemoglobin A
    Arya S; Binney ZO; Khakharia A; Long CA; Brewster LP; Wilson PW; Jordan WD; Duwayri Y
    J Vasc Surg; 2018 Jan; 67(1):217-228.e1. PubMed ID: 28844470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort.
    Lejeune S; Roy C; Slimani A; Pasquet A; Vancraeynest D; Vanoverschelde JL; Gerber BL; Beauloye C; Pouleur AC
    Cardiovasc Diabetol; 2021 Feb; 20(1):48. PubMed ID: 33608002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study.
    Yuan D; Jiang P; Zhu P; Jia S; Zhang C; Liu Y; Liu R; Xu J; Tang X; Zhao X; Gao R; Yang Y; Xu B; Gao Z; Yuan J
    Cardiovasc Diabetol; 2021 Jul; 20(1):143. PubMed ID: 34271936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a role for HbA1c in predicting mortality and morbidity outcomes after coronary artery bypass graft surgery?
    Tennyson C; Lee R; Attia R
    Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):1000-8. PubMed ID: 24021615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.